These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17184637)

  • 21. Coronary artery bypass grafting is superior to percutaneous coronary intervention in prevention of perioperative myocardial infarctions during subsequent vascular surgery.
    Ward HB; Kelly RF; Thottapurathu L; Moritz TE; Larsen GC; Pierpont G; Santilli S; Goldman S; Krupski WC; Littooy F; Reda DJ; McFalls EO
    Ann Thorac Surg; 2006 Sep; 82(3):795-800; discussion 800-1. PubMed ID: 16928485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.
    Sorajja P; Gersh BJ; Cox DA; McLaughlin MG; Zimetbaum P; Costantini C; Stuckey T; Tcheng JE; Mehran R; Lansky AJ; Grines CL; Stone GW
    Eur Heart J; 2007 Jul; 28(14):1709-16. PubMed ID: 17556348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment decisions in stable coronary artery disease: insights from the Euro Heart Survey on Coronary Revascularization.
    Breeman A; Hordijk-Trion M; Lenzen M; Hoeks S; Ottervanger JP; Bertrand ME; Sechtem U; Zaliunas R; Legrand V; de Boer MJ; Stahle E; Mercado N; Wijns W; Boersma E;
    J Thorac Cardiovasc Surg; 2006 Nov; 132(5):1001-9. PubMed ID: 17059915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
    Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):596-601. PubMed ID: 17667030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moderate-to-severe ischemic mitral regurgitation and multivessel coronary artery disease: Impact of different treatment on survival and rehospitalization.
    Buja P; Tarantini G; Del Bianco F; Razzolini R; Bilato C; Ramondo A; Napodano M; Isabella G; Gerosa G; Iliceto S
    Int J Cardiol; 2006 Jul; 111(1):26-33. PubMed ID: 16061295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of life in patients with symptomatic multivessel coronary artery disease: a comparative post hoc analyses of medical, angioplasty or surgical strategies-MASS II trial.
    Favarato ME; Hueb W; Boden WE; Lopes N; Nogueira CR; Takiuti M; Góis AF; Borges JC; Favarato D; Aldrighi JM; Oliveira SA; Ramires JA
    Int J Cardiol; 2007 Apr; 116(3):364-70. PubMed ID: 16876891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term survival after surgery versus percutaneous intervention in octogenarians with multivessel coronary disease.
    Dacey LJ; Likosky DS; Ryan TJ; Robb JF; Quinn RD; DeVries JT; Hearne MJ; Leavitt BJ; Dunton RF; Clough RA; Sisto D; Ross CS; Olmstead EM; O'Connor GT; Malenka DJ;
    Ann Thorac Surg; 2007 Dec; 84(6):1904-11; discussion 1904-11. PubMed ID: 18036905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occurrence and risk factors for reintervention after coronary artery bypass grafting.
    Sabik JF; Blackstone EH; Gillinov AM; Smedira NG; Lytle BW
    Circulation; 2006 Jul; 114(1 Suppl):I454-60. PubMed ID: 16820618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Family history, diabetes and extension of coronary atherosclerosis are strong predictors of adverse events after PTCA: A one-year follow-up study.
    Rizzo M; Barbagallo CM; Noto D; Pace A; Cefalú AB; Pernice V; Pinto V; Rubino A; Pieri D; Traina M; Frasheri A; Notarbartolo A; Averna MR
    Nutr Metab Cardiovasc Dis; 2005 Oct; 15(5):361-7. PubMed ID: 16216722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes is not a risk factor for hospital mortality following contemporary coronary artery bypass grafting.
    Filsoufi F; Rahmanian PB; Castillo JG; Mechanick JI; Sharma SK; Adams DH
    Interact Cardiovasc Thorac Surg; 2007 Dec; 6(6):753-8. PubMed ID: 17901106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
    Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
    J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Need for coronary artery bypass grafting in Newfoundland and Labrador: the impact of increased demand.
    Kent GM; Power L; Gregory DM; Barrett BJ; MacCallum GC; Stone EW; Parfrey PS
    Can J Cardiol; 2004 Mar; 20(4):399-404. PubMed ID: 15057315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival after percutaneous coronary intervention and coronary artery bypass grafting in a single centre.
    Mølstad P
    Scand Cardiovasc J; 2007 Aug; 41(4):214-20. PubMed ID: 17680508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of multivessel coronary disease after ST elevation myocardial infarction treated by primary angioplasty.
    Rigattieri S; Biondi-Zoccai G; Silvestri P; Di Russo C; Musto C; Ferraiuolo G; Loschiavo P
    J Interv Cardiol; 2008 Feb; 21(1):1-7. PubMed ID: 18086133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The beneficial effect of coronary-artery-bypass surgery on survival in patients with diabetic retinopathy.
    Ohno T; Ando J; Ono M; Morita T; Motomura N; Hirata Y; Takamoto S
    Eur J Cardiothorac Surg; 2006 Dec; 30(6):881-6. PubMed ID: 17052910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rationale for the revascularization arm of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
    Barsness GW; Gersh BJ; Brooks MM; Frye RL;
    Am J Cardiol; 2006 Jun; 97(12A):31G-40G. PubMed ID: 16813736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Revascularization in high risk patients: diabetes mellitus.
    Cola C; Sabaté M
    Minerva Cardioangiol; 2007 Oct; 55(5):557-77. PubMed ID: 17912163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated management of patients with diabetes mellitus and ischemic heart disease: PCI, CABG, and medical therapy.
    Barsness GW; Holmes DR; Gersh BJ
    Curr Probl Cardiol; 2005 Nov; 30(11):583-617. PubMed ID: 16230183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry).
    Steinberg BA; Steg PG; Bhatt DL; Fonarow GC; Zeymer U; Cannon CP;
    Am J Cardiol; 2007 May; 99(9):1212-5. PubMed ID: 17478144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term prognosis after coronary revascularization in patients with end-stage renal disease on dialysis: comparison of percutaneous coronary intervention and coronary artery bypass grafting].
    Fujimoto Y; Ishiwata S; Dohi T; Masuda J; Fujimoto H; Mitani H; Maehara A; Ohno M; Yamaguchi T; Tanaka K; Naruse Y
    J Cardiol; 2007 Jul; 50(1):11-20. PubMed ID: 17685025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.